Menu
Recruiting NCT05636384

SupporTive Care At Home Research for Patients With Advanced Cancer (STAHR-cancer)

No phase Interventional Malignant Neoplasm Home Care Services Quality of LIfe Unplanned Hospitalization

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Home-based care.
Who it may be relevant to
Registry conditions: Malignant Neoplasm, Home Care Services, Quality of LIfe, Unplanned Hospitalization. Basic parameters: from 19 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
South Korea
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

SupporTive Care At Home Research (STAHR): a Cluster Non-randomized Controlled Trial for Patients With Advanced Cancer

Overview

To test the effects of home-based care on unplanned hospitalization within 6 months among advanced cancer patients with decreased performance status. Home-based care includes education for patients and their family caregivers, home visits by specialized home-based medical staff, and regular status check-ups.

Detailed description

This study is a cluster, non-randomized controlled trial to test the effects of home-based care on unplanned hospitalization in 6 months among advanced cancer patients with decreased performance status. Home-based care includes education for patients and their family caregivers, home visits by specialized home-based medical staff, and regular status check-up. We are recruiting the study participants from 6 institutions, aiming for 396 cancer patients.

Participants for the intervention group will be recruited from Seoul National University Hospital, Chung-ang University Hospital, and Dongguk University Ilsan Hospital. Participants for the control group will be recruited from Kyung Hee University Medical Center, CHA Bundang Medical Center, and Seoul National University Bundang Hospital.

Interventions

  • Other Home-based care
    Home-based medical care is based on a specialized home-based medical team approach, including following: 1. Specialized Home-Based Medical Team Approach 2. Initial Assessment and Education 3. Initial Home Visits and Education 4. Multidisciplinary Team Meeting 5. Regular Assessment After the Initial Visit

Primary outcome measures

  • Unplanned hospitalization [Time frame: within 6 months following enrollment]
Secondary outcome measures (12)
  • Patient medical utilization [Time frame: within 6 months following enrollment]
  • Hospitalization [Time frame: within 6 months following enrollment]
  • ER visits [Time frame: within 6 months following enrollment]
  • Healthcare use [Time frame: within 6 months following enrollment]
  • Patient end-of-life care: ICU admission [Time frame: within 1 month before death]
  • Patient end-of-life care: ventilator treatment [Time frame: within 1 month before death]
  • Patient end-of-life care: an advance directive [Time frame: within 1 month before death]
  • Quality of life of patient - ESAS [Time frame: within 6 months following enrollment]
  • Quality of life of patient - EQ-5D [Time frame: within 6 months following enrollment]
  • Depressive symptom of patient [Time frame: within 6 months following enrollment]
  • Satisfaction with services (patient) [Time frame: within 6 months following enrollment]
  • Quality of life of family caregiver [Time frame: within 6 months following enrollment]

Eligibility criteria

Inclusion criteria

Both the patient and their family caregiver must meet the criteria to be considered for this research.

  • Patient
  • A person who has an advanced-stage solid cancer diagnosis (ICD-10 code C00-C70); A person who is receiving or planning to receive cancer treatment
  • A person who meets one of the following conditions
  • Has been evaluated as having ECOG performance status 2
  • Has been evaluated as having ECOG performance status 1 and is over 70 years of age
  • A person who wishes to stay at home
  • A person whose family caregiver resides at home
  • A person who wishes to participate in the research
  • Family Caregiver
  • A family\* member of the patient

\* Family: refers to the patient's spouse (including a common-law partner), descendants and their spouses up to the second degree, siblings and their spouses, and relatives and their spouses up to the eighth degree.

  • A person who meets one of the following conditions:
  • Lives with the patient (patient's household member)
  • Does not live with the patient, but visits the patient's home more than three times a week
  • A person who wants the patient to stay at home
  • A person who can communicate easily with medical staff
  • A person who wishes to participate in the research

Exclusion criteria

If either the patient or the family caregiver meets any one of these criteria, they are excluded from the study.

  • Patient
  • A person who cannot speak, hear, or read Korean
  • A person who is judged by a medical doctor to be unable to take part in this research due to extremely poor health
  • A person residing outside the range that can be visited by the respective medical institution (the conditions for distance are to be specified by each medical institution)\*

\* This condition is not applicable for the control group.

  • A person who has used hospital- or home-type hospice and palliative care services
  • A person who is under the age of 19
  • Family Caregiver
  • A person who cannot speak, hear, or read Korean
  • A person who is judged by a medical doctor to be unable to take part in this research due to extremely poor health
  • A person under the age of 19

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Non-randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Supportive care

Study locations

South Korea · 6 centers
  • Dongguk University Medical Center — Goyang-si
  • Bundang CHA Hospital — Seongnam-si
  • Seoul National University Bundang Hospital — Seongnam-si
  • Seoul National University Hospital — Seoul
  • Chung-Ang University Hosptial — Seoul
  • Kyung Hee University Hospital — Seoul

Identifiers

NCT: NCT05636384 · HC21C0115-1

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗